115 related articles for article (PubMed ID: 9267308)
21. Analysis of DNA restriction fragments and polymerase chain reaction products by capillary electrophoresis.
Williams PE; Marino MA; Del Rio SA; Turni LA; Devaney JM
J Chromatogr A; 1994 Oct; 680(2):525-40. PubMed ID: 7981833
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E2/E3/E4 genotyping with agarose gels.
Dallinga-Thie GM; van Linde-Sibenius Trip M; Kock LA; De Bruin TW
Clin Chem; 1995 Jan; 41(1):73-5. PubMed ID: 7813084
[TBL] [Abstract][Full Text] [Related]
23. Discovery and consequences of apolipoprotein-epsilon(3Groningen): a G-insertion in codon 95/96 that is predicted to cause a premature stop codon.
Dijck-Brouwer DA; van Doormaal JJ; Kema IP; Brugman AM; Kingma AW; Muskiet FA
Ann Clin Biochem; 2005 Jul; 42(Pt 4):264-8. PubMed ID: 15989726
[TBL] [Abstract][Full Text] [Related]
24. Correlation between RsaI restriction fragment length polymorphism and electrophoretic types of human placental alkaline phosphatase.
Beckman G; Beckman L; Lundgren E; Millán JL; Sikström C
Hum Hered; 1989; 39(1):41-5. PubMed ID: 2569440
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.
Lohse P; Mann WA; Stein EA; Brewer HB
J Biol Chem; 1991 Jun; 266(16):10479-84. PubMed ID: 1674745
[TBL] [Abstract][Full Text] [Related]
26. Comparative fingerprinting analysis of Campylobacter jejuni subsp. jejuni strains by amplified-fragment length polymorphism genotyping.
Lindstedt BA; Heir E; Vardund T; Melby KK; Kapperud G
J Clin Microbiol; 2000 Sep; 38(9):3379-87. PubMed ID: 10970387
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E genotyping methods for the clinical laboratory.
Maekawa B; Cole TG; Seip RL; Bylund D
J Clin Lab Anal; 1995; 9(1):63-9. PubMed ID: 7722775
[TBL] [Abstract][Full Text] [Related]
28. The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease.
Contois JH; Anamani DE; Tsongalis GJ
Clin Lab Med; 1996 Mar; 16(1):105-23. PubMed ID: 8867586
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration.
Wile DB; Barbir M; Gallagher J; Myant NB; Ritchie CD; Thompson GR; Humphries SE
Atherosclerosis; 1989 Jul; 78(1):9-18. PubMed ID: 2569310
[TBL] [Abstract][Full Text] [Related]
30. Rapid determination of apolipoprotein E genotype using a heteroduplex generator.
Bolla MK; Wood N; Humphries SE
J Lipid Res; 1999 Dec; 40(12):2340-5. PubMed ID: 10588960
[TBL] [Abstract][Full Text] [Related]
31. Terminal restriction fragment length polymorphism analysis of ribosomal RNA genes to assess changes in fungal community structure in soils.
Edel-Hermann V; Dreumont C; Pérez-Piqueres A; Steinberg C
FEMS Microbiol Ecol; 2004 Mar; 47(3):397-404. PubMed ID: 19712328
[TBL] [Abstract][Full Text] [Related]
32. DNA sequence analysis of Prinker-modified restriction fragments after collection from capillary electrophoresis with replaceable matrices.
Muth J; Müller O; Berka J; Leonard JT; Karger BL
J Chromatogr A; 1996 Sep; 744(1-2):303-10. PubMed ID: 8843679
[TBL] [Abstract][Full Text] [Related]
33. PCR-RFLP genotyping assay for the Bcl I polymorphism of the beta-fibrinogen gene.
Sell SM; Song C; Booyse FM
Genet Test; 2001; 5(1):45-6. PubMed ID: 11336400
[TBL] [Abstract][Full Text] [Related]
34. Analysis of polymerase chain reaction product by capillary electrophoresis and its application to the detection of single base substitution in genes.
Arakawa H; Uetanaka K; Maeda M; Tsuji A
J Chromatogr A; 1994 Mar; 664(1):89-98. PubMed ID: 7912142
[TBL] [Abstract][Full Text] [Related]
35. Genotyping of apolipoprotein A-IV by digestion of amplified DNA with restriction endonuclease Fnu4HI: use of a tailored primer to abolish additional recognition sites during the gene amplification.
Tenkanen H
J Lipid Res; 1991 Mar; 32(3):545-9. PubMed ID: 1676720
[TBL] [Abstract][Full Text] [Related]
36. A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys).
Kobayashi J; Shirai K; Murano T; Misawa Y; Tashiro J; Yoshida T; Shinomiya M
Biochim Biophys Acta; 2002 Jun; 1583(1):117-21. PubMed ID: 12069856
[TBL] [Abstract][Full Text] [Related]
37. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene.
Artiga MJ; Bullido MJ; Sastre I; Recuero M; García MA; Aldudo J; Vázquez J; Valdivieso F
FEBS Lett; 1998 Jan; 421(2):105-8. PubMed ID: 9468288
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E genotyping and phenotyping in type II diabetes mellitus patients with hypertriglyceridemia.
Kim JH; Lee EJ; Kwon OH
Clin Biochem; 1997 Feb; 30(1):47-52. PubMed ID: 9056109
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein (apo) E genotypes by polymerase chain reaction and allele-specific oligonucleotide probes: no detectable linkage disequilibrium between apo E and apo CII.
Houlston RS; Snowden C; Green F; Alberti KG; Humphries SE
Hum Genet; 1989 Nov; 83(4):364-8. PubMed ID: 2572535
[TBL] [Abstract][Full Text] [Related]
40. Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity.
Srivastava N; Achyut BR; Prakash J; Agarwal CG; Pant DC; Mittal B
Mol Cell Biochem; 2008 Jul; 314(1-2):171-7. PubMed ID: 18454345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
